SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-024064
Filing Date
2019-06-28
Accepted
2019-06-28 16:15:36
Documents
4
Period of Report
2019-06-28
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-8k_20190628.htm 8-K 39976
2 EX-3.1 life-ex31_7.htm EX-3.1 12939
3 EX-99.1 life-ex991_6.htm EX-99.1 14656
4 GRAPHIC gpqxk5ian2hj000001.jpg GRAPHIC 17344
  Complete submission text file 0001564590-19-024064.txt   92873
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 19929542
SIC: 2836 Biological Products, (No Diagnostic Substances)